Global Veno-Arterial ECMO System Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
According to our (Global Info Research) latest study, the global Veno-Arterial ECMO System market size was valued at USD 262.1 million in 2022 and is forecast to a readjusted size of USD 321.6 million by 2029 with a CAGR of 3.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe region is the largest supplier of Veno-Arterial ECMO System, with a production market share nearly 42%. North America is the second largest supplier of Veno-Arterial ECMO System, enjoying production market share nearly 36%. North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
This report is a detailed and comprehensive analysis for global Veno-Arterial ECMO System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veno-Arterial ECMO System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Veno-Arterial ECMO System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Veno-Arterial ECMO System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Veno-Arterial ECMO System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veno-Arterial ECMO System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veno-Arterial ECMO System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Maquet Holding, Sorin Group, Terumo and Xenios AG. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Veno-Arterial ECMO System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Portable Veno-Arterial ECMO System
    Fixed Veno-Arterial ECMO System
Market segment by Application
    Neonatal
    Pediatric
    Adult
Major players covered
    Medtronic
    Maquet Holding
    Sorin Group
    Terumo
    Xenios AG
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veno-Arterial ECMO System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veno-Arterial ECMO System, with price, sales, revenue and global market share of Veno-Arterial ECMO System from 2018 to 2023.
Chapter 3, the Veno-Arterial ECMO System competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veno-Arterial ECMO System breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veno-Arterial ECMO System market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veno-Arterial ECMO System.
Chapter 14 and 15, to describe Veno-Arterial ECMO System sales channel, distributors, customers, research findings and conclusion.